Free tool
FAERS Monitor: Penicillin G Potassium In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050638 or its brand name (Penicillin G Potassium In Plastic Container, Penicillin G Potassium). Reports on generic versions are filed under their own applications.
Reports
2,352
Serious
1,747
74% of reports
Hospitalization
821
Death reported
241
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity671
- drug ineffective342
- rash244
- dyspnoea243
- diarrhoea233
- nausea214
- off label use209
- malaise199
- drug intolerance192
- abdominal pain upper180
- cough161
- headache157
- arthralgia150
- hypersensitivity150
- anxiety143
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 18 |
| 2005 | 20 |
| 2006 | 29 |
| 2007 | 57 |
| 2008 | 29 |
| 2009 | 37 |
| 2010 | 28 |
| 2011 | 45 |
| 2012 | 140 |
| 2013 | 29 |
| 2014 | 24 |
| 2015 | 28 |
| 2016 | 40 |
| 2017 | 60 |
| 2018 | 113 |
| 2019 | 141 |
| 2020 | 155 |
| 2021 | 200 |
| 2022 | 296 |
| 2023 | 316 |
| 2024 | 253 |
| 2025 | 196 |
| 2026 | 98 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,807 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 671 | 31.1 | 29.2 | 19,638 |
| drug intoleranceSignal | 192 | 17.8 | 15.5 | 3,037 |
| abdominal pain upperSignal | 180 | 7.8 | 6.8 | 1,074 |
| hypersensitivitySignal | 150 | 7.2 | 6.2 | 806 |
| coughSignal | 161 | 5.1 | 4.4 | 539 |
| rashSignal | 244 | 5.0 | 4.4 | 795 |
| anxietySignal | 143 | 4.5 | 3.8 | 390 |
| malaiseSignal | 199 | 4.1 | 3.6 | 465 |
| dyspnoeaSignal | 243 | 3.8 | 3.4 | 521 |
| diarrhoeaSignal | 233 | 3.2 | 2.9 | 367 |
| arthralgiaSignal | 150 | 3.2 | 2.8 | 233 |
| nauseaSignal | 214 | 2.4 | 2.1 | 183 |
| drug ineffectiveSignal | 342 | 2.3 | 2.1 | 273 |
| headacheSignal | 157 | 2.2 | 1.9 | 110 |
| off label useSignal | 209 | 2.1 | 1.9 | 130 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.